Biotech · Private company
Rubius Therapeutics
Track this companyFree. Adds Rubius Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- PembrolizumabPhase 2 · Solid Tumor, AML AdultClinicalTrials.gov · fetched Nov 12, 2026
- RTX-224Phase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- RTX-240Phase 2 · Solid Tumor, AML AdultClinicalTrials.gov · fetched Nov 12, 2026
- RTX-134Phase 1 · PhenylketonuriasClinicalTrials.gov · fetched Nov 12, 2026
- RTX-321Phase 1 · Cervical CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- RTX-224 Monotherapy in Patients With Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jan 12, 2022ClinicalTrials.gov NCT05219578 · fetched Nov 12, 2026
- RTX-321 Monotherapy in Patients With HPV 16+ TumorsPHASE1 · TERMINATED · started Apr 8, 2021ClinicalTrials.gov NCT04672980 · fetched Nov 12, 2026
- RTX-240 Monotherapy and in Combination With PembrolizumabPHASE1_PHASE2 · TERMINATED · started May 6, 2020ClinicalTrials.gov NCT04372706 · fetched Nov 12, 2026
- Safety and Tolerability of RTX-134 in Adults With PhenylketonuriaPHASE1 · TERMINATED · started Jan 29, 2020ClinicalTrials.gov NCT04110496 · fetched Nov 12, 2026